News Website

From access barriers to inclusive design: Redesigning trials for women - FemTech World

From access barriers to inclusive design: Redesigning trials for women FemTech World

Published: March 3, 2026, 8:39 a.m.

Read Full Article

Mechanism study of phthalate exposure promoting endometriosis: Based on the ferroptosis perspective.

Phthalates (PAEs), typical endocrine-disrupting chemicals (EDCs) that accumulate in the human body to induce reproductive toxicity, have epidemiological links to endometriosis (EM), but the underlying micro-mechanisms remain unclear. Ferroptosis is …

Published: March 2, 2026, midnight

Read Full Article

Bioinformatics Endometriosis Network toxicology Phthalates ScRNA-seq

“This Is Endometriosis” Wins BAFTA for Best British Short Film - Femtech Insider

“This Is Endometriosis” Wins BAFTA for Best British Short Film Femtech Insider

Published: Feb. 25, 2026, 11:48 a.m.

Read Full Article

Femtech FimmCyte closes wide-ranging agreement with Richter - Startupticker.ch

Femtech FimmCyte closes wide-ranging agreement with Richter Startupticker.ch

Published: Feb. 19, 2026, 5:01 p.m.

Read Full Article

Richter signs endometriosis antibody deal - FemTech World

Richter signs endometriosis antibody deal FemTech World

Published: Feb. 19, 2026, 2:03 p.m.

Read Full Article

Japanese pharmas team up on AI-led gynaecology drug research - FemTech World

Japanese pharmas team up on AI-led gynaecology drug research FemTech World

Published: Feb. 19, 2026, 1:03 p.m.

Read Full Article

Endometriosis-sufferer wins landmark tribunal case on workplace discrimination - FemTech World

Endometriosis-sufferer wins landmark tribunal case on workplace discrimination FemTech World

Published: Feb. 19, 2026, 9:02 a.m.

Read Full Article

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.

Read Full Article

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.

Read Full Article

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Feb. 18, 2026, 3:18 p.m.

Read Full Article

Latest Articles

From access barriers to inclusive design: Redesigning trials for women - FemTech World

Mechanism study of phthalate exposure promoting endometriosis: Based on the ferroptosis perspective.

“This Is Endometriosis” Wins BAFTA for Best British Short Film - Femtech Insider

Femtech FimmCyte closes wide-ranging agreement with Richter - Startupticker.ch

Richter signs endometriosis antibody deal - FemTech World

Japanese pharmas team up on AI-led gynaecology drug research - FemTech World

Endometriosis-sufferer wins landmark tribunal case on workplace discrimination - FemTech World

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

Subscribe to Our Newsletter